A selection of eye drops line a shelf at a pharmacy in Los Angeles on Tuesday, Dec. 12, 2023. Repeated recalls of eyedrops are drawing new attention to the limited powers U.S. regulators have to oversee medical products made overseas. Unlike prescription drugs, eyedrops and other over-the-counter products don't get preliminary review by the Food and Drug Administration. (AP Photo/Richard Vogel)
Featured Photo Galleries
